soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized Effects of oral semaglutide on

Metformin and insulin are considered safe and effective options for managing type 2 diabetes during breastfeeding, with extensive evidence supporting their use and recommendations from NICE and the BNF

Fear of Long-Term Use Concerns about the long-term safety of GLP-1s stop many people from committing to them

Full details of the model are in paper3

Summary: Plasma donation eligibility whilst taking Wegovy (semaglutide) is determined by NHS Blood and Transplant on an individual basis, considering the medication, underlying health conditions, and current wellbeing

Less common but serious side effects, including pancreatitis, gallbladder issues, and changes in kidney function, have been reported

Yellow flags worth discussing at your next appointment These are not emergencies but deserve conversation with your prescriber